Luca Palazzo

9PUBLICATIONS
12CO-AUTHORS
Patient safetyBiologically active moleculesRegenerative medicine (incl. stem cells)Polymerisation mechanismsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 05, 2026
Histidine and tyrosine residues are targets for SIRT6 ADP-ribosylation activity.

Johannes Gregor Matthias Rack, Evgeniia Prokhorova, Raffaella Lauro

|Feb 25, 2023
The DarT/DarG Toxin-Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies.

Giuliana Catara, Rocco Caggiano, Luca Palazzo

|Jan 14, 2021
Mono(ADP-ribosyl)ation Enzymes and NAD+ Metabolism: A Focus on Diseases and Therapeutic Perspectives.

Palmiro Poltronieri, Angela Celetti, Luca Palazzo

|Aug 14, 2020
Progress and outlook in studying the substrate specificities of PARPs and related enzymes.

Marcin J Suskiewicz, Luca Palazzo, Rebecca Hughes

|Oct 20, 2019
CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC.

Francesco Morra, Francesco Merolla, Ida Picardi

|Nov 14, 2018
PARPs in genome stability and signal transduction: implications for cancer therapy.

Luca Palazzo, Ivan Ahel

Pageof 2

Frequent Collaborators

5 joint publications

Ivan Ahel

2 joint publications

Ivan Matic

1 joint publications

Juan José Bonfiglio

1 joint publications

Orsolya Leidecker